Back to company

SPECIFIC PHARMA A/S: Financial statements 2021

CVR: 33161395

SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 139,630,000 and a net result of DKK 14,799,000 compared with DKK 8,237,000 the year before. That is an increase of 8.9% compared with the year before. The profit margin was 10.6%. Equity amounted to DKK 88,820,000. The solvency ratio was 82.8%. The company had 21 employees in the financial year.

Revenue
139,630,000 kr.
Gross Profit
32,541,000 kr.
Profit/Loss
14,799,000 kr.
Equity
88,820,000 kr.
Total Assets
107,235,000 kr.
Employees
21

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021139.6 mio.32.5 mio.14.8 mio.88.8 mio.21
2020128.2 mio.27 mio.8.2 mio.80.2 mio.16
2019146.4 mio.25.3 mio.8.9 mio.78.6 mio.15
2018145.7 mio.29.7 mio.14.8 mio.69.7 mio.12
2017142.4 mio.41.9 mio.26.2 mio.74.6 mio.8

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like SPECIFIC PHARMA A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

About SPECIFIC PHARMA A/S

SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The company is owned by NOMECO A/S. The company has 24 employees. In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity amounted to DKK 98,645,000.